Tech Company Financing Transactions

Cerexa Funding Round

On 8/23/2005, Cerexa announced $50 million in Series A funding from Frazier Healthcare Partners, Canaan Partners and CDIB Bioscience.

Transaction Overview

Company Name
Announced On
8/23/2005
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series A
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
2100 Franklin St. 900
Oakland, CA 94612
USA
Email Address
Overview
Forest Laboratories, Inc. (NYSE: FRX) is a U.S.-based pharmaceutical company with a long track record of building partnerships.
Profile
Cerexa LinkedIn Company Profile
Social Media
Cerexa Company Twitter Account
Company News
Cerexa News
Facebook
Cerexa on Facebook
YouTube
Cerexa on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Brenton Saunders
  Brenton Saunders LinkedIn Profile  Brenton Saunders Twitter Account  Brenton Saunders News  Brenton Saunders on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/23/2005: Nsite venture capital transaction
Next: 8/24/2005: ClairMail venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary